{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T07:07:18Z","timestamp":1780643238242,"version":"3.54.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN154311"],"award-info":[{"award-number":["FDN154311"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN154311"],"award-info":[{"award-number":["FDN154311"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN154311"],"award-info":[{"award-number":["FDN154311"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN154311"],"award-info":[{"award-number":["FDN154311"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN154311"],"award-info":[{"award-number":["FDN154311"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN154311"],"award-info":[{"award-number":["FDN154311"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-19204-2","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:46:10Z","timestamp":1759171570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Plasma apolipoprotein A-I is a causal protective factor in sepsis"],"prefix":"10.1038","volume":"15","author":[{"given":"Kyle R.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kantimas","family":"Sitthikool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly Roveran","family":"Genga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadanaga","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taka-aki","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith R.","family":"Walley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"19204_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00134-006-0432-y","volume":"33","author":"O Murch","year":"2007","unstructured":"Murch, O., Collin, M., Hinds, C. J. & Thiemermann, C. Lipoproteins in inflammation and sepsis. I. Basic science. Intensive Care Med. 33, 13\u201324 (2007).","journal-title":"Intensive Care Med."},{"key":"19204_CR2","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1128\/IAI.71.6.3280-3284.2003","volume":"71","author":"JHM Levels","year":"2003","unstructured":"Levels, J. H. M., Abraham, P. R., van Barreveld, E. P., Meijers, J. C. M. & van Deventer, S. J. H. Distribution and kinetics of lipoprotein-bound Lipoteichoic acid. Infect. Immun. 71, 3280\u20133284 (2003).","journal-title":"Infect. Immun."},{"key":"19204_CR3","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1128\/IAI.73.4.2321-2326.2005","volume":"73","author":"JHM Levels","year":"2005","unstructured":"Levels, J. H. M. et al. Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein. Infect. Immun. 73, 2321\u20132326 (2005).","journal-title":"Infect. Immun."},{"key":"19204_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/abbs\/36.6.419","volume":"36","author":"J Ma","year":"2004","unstructured":"Ma, J., Liao, X-L., Lou, B. & Wu, M-P. Role of Apolipoprotein A-I in protecting against endotoxin toxicity. Acta Biochim. Biophys. Sin (Shanghai). 36, 419\u2013424 (2004).","journal-title":"Acta Biochim. Biophys. Sin (Shanghai)"},{"key":"19204_CR5","doi-asserted-by":"publisher","first-page":"12040","DOI":"10.1073\/pnas.90.24.12040","volume":"90","author":"DM Levine","year":"1993","unstructured":"Levine, D. M., Parker, T. S., Donnelly, T. M., Walsh, A. & Rubin, A. L. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl. Acad. Sci. U. S. A. 90, 12040\u201312044 (1993).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"19204_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0022-2275(20)33363-0","volume":"40","author":"C Grunfeld","year":"1999","unstructured":"Grunfeld, C. et al. Lipoproteins inhibit macrophage activation by Lipoteichoic acid. J. Lipid Res. 40, 245\u2013252 (1999).","journal-title":"J. Lipid Res."},{"key":"19204_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ejphar.2008.06.047","volume":"590","author":"Y Li","year":"2008","unstructured":"Li, Y., Dong, J-B. & Wu, M-P. Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice. Eur. J. Pharmacol. 590, 417\u2013422 (2008).","journal-title":"Eur. J. Pharmacol."},{"key":"19204_CR8","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1097\/00003246-200108000-00011","volume":"29","author":"BR Gordon","year":"2001","unstructured":"Gordon, B. R. et al. Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. Crit. Care Med. 29, 1563\u20131568 (2001).","journal-title":"Crit. Care Med."},{"key":"19204_CR9","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1097\/01.CCM.0000059724.08290.51","volume":"31","author":"HJ van Leeuwen","year":"2003","unstructured":"van Leeuwen, H. J. et al. Lipoprotein metabolism in patients with severe sepsis. Crit. Care Med. 31, 1359\u20131366 (2003).","journal-title":"Crit. Care Med."},{"key":"19204_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/01.shk.0000111661.09279.82","volume":"21","author":"A Wu","year":"2004","unstructured":"Wu, A., Hinds, C. J. & Thiemermann, C. High-density lipoproteins in sepsis and septic shock: Metabolism, actions, and therapeutic applications. Shock 21, 210\u2013221 (2004).","journal-title":"Shock"},{"key":"19204_CR11","first-page":"e0860","volume":"5","author":"DA Hofmaenner","year":"2023","unstructured":"Hofmaenner, D. A. et al. Association between hypocholesterolemia and mortality in critically ill patients with sepsis: A systematic review and meta-analysis. Crit. Care Explor. 5, e0860 (2023).","journal-title":"Crit. Care Explor."},{"key":"19204_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13613-021-00800-0","volume":"11","author":"S Tanaka","year":"2021","unstructured":"Tanaka, S. et al. Relationship between lipoprotein concentrations and short-term and 1-year mortality in intensive care unit septic patients: Results from the HIGHSEPS study. Ann. Intensive Care. 11, 11 (2021).","journal-title":"Ann. Intensive Care"},{"key":"19204_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13613-021-00865-x","volume":"11","author":"FW Guirgis","year":"2021","unstructured":"Guirgis, F. W. et al. Lipid and lipoprotein predictors of functional outcomes and long-term mortality after surgical sepsis. Ann. Intensive Care. 11, 82 (2021).","journal-title":"Ann. Intensive Care"},{"key":"19204_CR14","doi-asserted-by":"publisher","first-page":"1217922","DOI":"10.3389\/fcvm.2023.1217922","volume":"10","author":"C Lou","year":"2023","unstructured":"Lou, C. et al. Genetic association of lipids and lipid-lowering drugs with sepsis: A Mendelian randomization and mediation analysis. Front. Cardiovasc. Med. 10, 1217922 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"19204_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40560-025-00782-2","volume":"13","author":"N Takahashi","year":"2025","unstructured":"Takahashi, N. et al. Low Apolipoprotein A-II levels causally contribute to increased mortality in septic shock. J. Intensive Care. 13, 10 (2025).","journal-title":"J. Intensive Care"},{"key":"19204_CR16","doi-asserted-by":"publisher","first-page":"11122","DOI":"10.1038\/ncomms11122","volume":"7","author":"J Kettunen","year":"2016","unstructured":"Kettunen, J. et al. Genome-wide study for Circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. Nat. Commun. 7, 11122 (2016).","journal-title":"Nat. Commun."},{"key":"19204_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"19204_CR18","doi-asserted-by":"publisher","first-page":"e1004174","DOI":"10.1371\/journal.pmed.1004174","volume":"20","author":"FW Hamilton","year":"2023","unstructured":"Hamilton, F. W. et al. Therapeutic potential of IL6R Blockade for the treatment of sepsis and sepsis-related death: A Mendelian randomisation study. PLoS Med. 20, e1004174 (2023).","journal-title":"PLoS Med."},{"key":"19204_CR19","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"JA Russell","year":"2008","unstructured":"Russell, J. A. et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N. Engl. J. Med. 358, 877\u2013887 (2008).","journal-title":"N Engl. J. Med."},{"key":"19204_CR20","doi-asserted-by":"publisher","first-page":"e022482","DOI":"10.1161\/JAHA.121.022482","volume":"10","author":"J Leskel\u00e4","year":"2021","unstructured":"Leskel\u00e4, J. et al. Genetic profile of endotoxemia reveals an association with thromboembolism and stroke. J. Am. Heart Assoc. 10, e022482 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"19204_CR21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00134-021-06410-5","volume":"47","author":"M Du","year":"2021","unstructured":"Du, M. et al. Integrative omics provide biological and clinical insights into acute respiratory distress syndrome. Intensive Care Med. 47, 761\u2013771 (2021).","journal-title":"Intensive Care Med."},{"key":"19204_CR22","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41586-021-03767-x","volume":"600","author":"COVID-19 Host Genetics Initiative","year":"2021","unstructured":"COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature 600, 472\u2013477 (2021).","journal-title":"Nature"},{"key":"19204_CR23","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.2797","volume":"45","author":"CJ Willer","year":"2013","unstructured":"Willer, C. J. et al. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45, 1274\u20131283 (2013).","journal-title":"Nat. Genet."},{"key":"19204_CR24","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova, V. W. et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: The STROBE-MR statement. JAMA 326, 1614\u20131621 (2021).","journal-title":"JAMA"},{"key":"19204_CR25","doi-asserted-by":"publisher","first-page":"n2233","DOI":"10.1136\/bmj.n2233","volume":"375","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova, V. W. et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomisation (STROBE-MR): Explanation and elaboration. BMJ 375, n2233 (2021).","journal-title":"BMJ"},{"key":"19204_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1161\/ATVBAHA.119.313381","volume":"40","author":"M Trinder","year":"2020","unstructured":"Trinder, M., Walley, K. R., Boyd, J. H. & Brunham, L. R. Causal inference for genetically determined levels of high-density lipoprotein cholesterol and risk of infectious disease. Arterioscler. Thromb. Vasc Biol. 40, 267\u2013278 (2020).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"19204_CR27","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/ALN.0000000000003155","volume":"132","author":"S Tanaka","year":"2020","unstructured":"Tanaka, S. et al. Reconstituted high-density lipoprotein therapy improves survival in mouse models of sepsis. Anesthesiology 132, 825\u2013838 (2020).","journal-title":"Anesthesiology"},{"key":"19204_CR28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13613-019-0541-8","volume":"9","author":"S Tanaka","year":"2019","unstructured":"Tanaka, S. et al. High-density lipoprotein (HDL) particle size and concentration changes in septic shock patients. Ann. Intensive Care. 9, 68 (2019).","journal-title":"Ann. Intensive Care"},{"key":"19204_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12014-019-9252-2","volume":"16","author":"NK Sharma","year":"2019","unstructured":"Sharma, N. K. et al. Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis. Clin. Proteom. 16, 29 (2019).","journal-title":"Clin. Proteom."},{"key":"19204_CR30","doi-asserted-by":"publisher","first-page":"15606","DOI":"10.1038\/s41598-017-15755-1","volume":"7","author":"NK Sharma","year":"2017","unstructured":"Sharma, N. K. et al. Proteomic study revealed cellular assembly and lipid metabolism dysregulation in sepsis secondary to community-acquired pneumonia. Sci. Rep. 7, 15606 (2017).","journal-title":"Sci. Rep."},{"key":"19204_CR31","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s00134-009-1609-y","volume":"35","author":"S Barlage","year":"2009","unstructured":"Barlage, S. et al. Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation. Intensive Care Med. 35, 1877\u20131885 (2009).","journal-title":"Intensive Care Med."},{"key":"19204_CR32","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/01.CCM.0000114820.47460.0A","volume":"32","author":"C Chenaud","year":"2004","unstructured":"Chenaud, C. et al. Low Apolipoprotein A-I level at intensive care unit admission and systemic inflammatory response syndrome exacerbation. Crit. Care Med. 32, 632\u2013637 (2004).","journal-title":"Crit. Care Med."},{"key":"19204_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s12291-015-0513-1","volume":"31","author":"M Mangaraj","year":"2016","unstructured":"Mangaraj, M., Nanda, R. & Panda, S. Apolipoprotein A-I: A molecule of diverse function. Indian J. Clin. Biochem. 31, 253\u2013259 (2016).","journal-title":"Indian J. Clin. Biochem."},{"key":"19204_CR34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/1753425910370709","volume":"17","author":"MF Henning","year":"2011","unstructured":"Henning, M. F., Herlax, V. & Bak\u00e1s, L. Contribution of the C-terminal end of Apolipoprotein AI to neutralization of lipopolysaccharide endotoxic effect. Innate Immun. 17, 327\u2013337 (2011).","journal-title":"Innate Immun."},{"key":"19204_CR35","doi-asserted-by":"publisher","first-page":"5140","DOI":"10.1128\/iai.61.12.5140-5146.1993","volume":"61","author":"WA Flegel","year":"1993","unstructured":"Flegel, W. A., Baumstark, M. W., Weinstock, C., Berg, A. & Northoff, H. Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by Apolipoprotein A-I. Infect. Immun. 61, 5140\u20135146 (1993).","journal-title":"Infect. Immun."},{"key":"19204_CR36","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.4049\/jimmunol.1100253","volume":"187","author":"MB Fessler","year":"2011","unstructured":"Fessler, M. B. & Parks, J. S. Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling. J. Immunol. 187, 1529\u20131535 (2011).","journal-title":"J. Immunol."},{"key":"19204_CR37","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/ATVBAHA.110.207142","volume":"30","author":"L Yvan-Charvet","year":"2010","unstructured":"Yvan-Charvet, L. et al. Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib. Arterioscler. Thromb. Vasc Biol. 30, 1430\u20131438 (2010).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"19204_CR38","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1161\/CIRCULATIONAHA.110.961193","volume":"122","author":"M Suzuki","year":"2010","unstructured":"Suzuki, M. et al. High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide. Circulation 122, 1919\u20131927 (2010).","journal-title":"Circulation"},{"key":"19204_CR39","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1016\/j.febslet.2008.10.006","volume":"582","author":"PS Kabouridis","year":"2008","unstructured":"Kabouridis, P. S. & Jury, E. C. Lipid rafts and T-lymphocyte function: Implications for autoimmunity. FEBS Lett. 582, 3711\u20133718 (2008).","journal-title":"FEBS Lett."},{"key":"19204_CR40","doi-asserted-by":"publisher","first-page":"17947","DOI":"10.1074\/jbc.M112.442699","volume":"288","author":"L Guo","year":"2013","unstructured":"Guo, L. et al. High density lipoprotein protects against polymicrobe-induced sepsis in mice. J. Biol. Chem. 288, 17947\u201317953 (2013).","journal-title":"J. Biol. Chem."},{"key":"19204_CR41","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1097\/01.CCM.0000171183.79525.6B","volume":"33","author":"J-Y Chien","year":"2005","unstructured":"Chien, J-Y., Jerng, J-S., Yu, C-J. & Yang, P-C. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit. Care Med. 33, 1688\u20131693 (2005).","journal-title":"Crit. Care Med."},{"key":"19204_CR42","doi-asserted-by":"publisher","first-page":"9644","DOI":"10.1016\/S0021-9258(18)67562-3","volume":"261","author":"GA Coetzee","year":"1986","unstructured":"Coetzee, G. A. et al. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and Apolipoprotein composition. J. Biol. Chem. 261, 9644\u20139651 (1986).","journal-title":"J. Biol. Chem."},{"key":"19204_CR43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/00041433-200104000-00006","volume":"12","author":"G Schmitz","year":"2001","unstructured":"Schmitz, G. & Langmann, T. Structure, function and regulation of the ABC1 gene product. Curr. Opin. Lipidol. 12, 129\u2013140 (2001).","journal-title":"Curr. Opin. Lipidol."},{"key":"19204_CR44","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1161\/01.CIR.100.15.e65","volume":"100","author":"RP Choudhury","year":"1999","unstructured":"Choudhury, R. P. & Leyva, F. C-Reactive protein, serum amyloid A protein, and coronary events. Circulation 100, e65\u201366 (1999).","journal-title":"Circulation"},{"key":"19204_CR45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.atherosclerosis.2004.04.018","volume":"176","author":"W Khovidhunkit","year":"2004","unstructured":"Khovidhunkit, W. et al. Apolipoproteins A-IV and A-V are acute-phase proteins in mouse HDL. Atherosclerosis 176, 37\u201344 (2004).","journal-title":"Atherosclerosis"},{"key":"19204_CR46","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1172\/JCI10852","volume":"107","author":"G Martin","year":"2001","unstructured":"Martin, G. et al. Statin-induced Inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I. J. Clin. Invest. 107, 1423\u20131432 (2001).","journal-title":"J. Clin. Invest."},{"key":"19204_CR47","first-page":"82","volume":"17","author":"R Yazdani","year":"2018","unstructured":"Yazdani, R. et al. Effect of aerobic exercises on serum levels of Apolipoprotein A1 and Apolipoprotein B, and their ratio in patients with chronic obstructive pulmonary disease. Tanaffos 17, 82\u201389 (2018).","journal-title":"Tanaffos"},{"key":"19204_CR48","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.atherosclerosis.2011.04.026","volume":"218","author":"R Sol\u00e1","year":"2011","unstructured":"Sol\u00e1, R. et al. Effect of a traditional mediterranean diet on apolipoproteins B, A-I, and their ratio: a randomized, controlled trial. Atherosclerosis 218, 174\u2013180 (2011).","journal-title":"Atherosclerosis"},{"key":"19204_CR49","doi-asserted-by":"publisher","first-page":"101395","DOI":"10.1016\/j.cpcardiol.2022.101395","volume":"48","author":"TL Wilkens","year":"2023","unstructured":"Wilkens, T. L. et al. Associations between alcohol consumption and HDL subspecies defined by ApoC3, ApoE and apoj: The cardiovascular health study. Curr. Probl. Cardiol. 48, 101395 (2023).","journal-title":"Curr. Probl. Cardiol."},{"key":"19204_CR50","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1056\/NEJMoa1604304","volume":"375","author":"BA Ference","year":"2016","unstructured":"Ference, B. A. et al. Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes. N Engl. J. Med. 375, 2144\u20132153 (2016).","journal-title":"N Engl. J. Med."},{"key":"19204_CR51","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12916-023-03057-5","volume":"21","author":"A Stasi","year":"2023","unstructured":"Stasi, A. et al. Beneficial effects of Recombinant CER-001 high-density lipoprotein infusion in sepsis: Results from a bench to bedside translational research project. BMC Med. 21, 392 (2023).","journal-title":"BMC Med."}],"updated-by":[{"DOI":"10.1038\/s41598-026-40588-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19204-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19204-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19204-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:03:43Z","timestamp":1771326223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19204-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19204"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19204-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"9 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-40588-2","URL":"https:\/\/doi.org\/10.1038\/s41598-026-40588-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and consent to participate in each cohort is listed in the Methods section of the main manuscript. The study protocol of each cohort was approved by the institutional review board at each participating site.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approve this study submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33625"}}